1244 related articles for article (PubMed ID: 16094773)
1. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
Zelenay JL
Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
[No Abstract] [Full Text] [Related]
2. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
Bierut MB
Healthspan; 1992 Dec; 9(11):12-4. PubMed ID: 10123552
[No Abstract] [Full Text] [Related]
3. Drug safety reform at the FDA--pendulum swing or systematic improvement?
McClellan M
N Engl J Med; 2007 Apr; 356(17):1700-2. PubMed ID: 17435081
[No Abstract] [Full Text] [Related]
4. Paying for drug approvals--who's using whom?
Avorn J
N Engl J Med; 2007 Apr; 356(17):1697-700. PubMed ID: 17435083
[No Abstract] [Full Text] [Related]
5. PDUFA reauthorization--drug safety's golden moment of opportunity?
Hennessy S; Strom BL
N Engl J Med; 2007 Apr; 356(17):1703-4. PubMed ID: 17435082
[No Abstract] [Full Text] [Related]
6. What ails the FDA?
Okie S
N Engl J Med; 2005 Mar; 352(11):1063-6. PubMed ID: 15784660
[No Abstract] [Full Text] [Related]
7. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
8. FDA and drug safety: new Tufts study challenges critics of the Prescription Drug User Fee Act.
Lee R
J Law Med Ethics; 2006; 34(1):131-4. PubMed ID: 16489994
[No Abstract] [Full Text] [Related]
9. The impact of FDA reform.
Trunzo J
Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
[TBL] [Abstract][Full Text] [Related]
10. Regulatory watch: impact of PDUFA on regulatory decision-making.
Hay M
Nat Rev Drug Discov; 2010 Aug; 9(8):585. PubMed ID: 20671755
[No Abstract] [Full Text] [Related]
11. User fees for faster drug reviews. Are they helping or hurting the public health?
Thompson L
FDA Consum; 2000; 34(5):25-9. PubMed ID: 11590789
[No Abstract] [Full Text] [Related]
12. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
Purnhagen KP
Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
[No Abstract] [Full Text] [Related]
13. FDA user fees approved.
Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431
[No Abstract] [Full Text] [Related]
14. New drug law to speed scientific review.
Nature; 1992 Oct; 359(6396):563. PubMed ID: 1406977
[TBL] [Abstract][Full Text] [Related]
15. FDA attempting to overcome major roadblocks in monitoring drug safety.
Zielinski SL
J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
[No Abstract] [Full Text] [Related]
17. User fees to fund faster reviews.
Henkel J
FDA Consum; 1993 Oct; 27(8):19-21. PubMed ID: 10129049
[No Abstract] [Full Text] [Related]
18. FDA user fee plan gets some support from drug makers.
Weissenstein E
Mod Healthc; 1992 Aug; 22(33):20. PubMed ID: 10119804
[No Abstract] [Full Text] [Related]
19. HHS: POUFA reauthorization good for Americans.
FDA Consum; 2002; 36(5):5. PubMed ID: 12412536
[No Abstract] [Full Text] [Related]
20. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]